Peripheral arterial disease in patients with stages IV and V chronic renal failure

被引:63
作者
Guerrero, Angeles
Montes, Rafael
Munoz-Terol, Jose
Gil-Peralta, Alberto
Toro, Javier
Naranjo, Macarena
Gonzalez-Perez, Paloma
Martin-Herrera, Carmen
Ruiz-Fernandez, Ana
机构
[1] Univ Hosp Virgen del Rocio, Dept Nephrol, Seville, Spain
[2] Univ Hosp Virgen del Rocio, Dept Neurol, Seville, Spain
关键词
ankle-brachial index; cardiovascular risk factors; chronic renal failure; peripheral arterial disease;
D O I
10.1093/ndt/gfl470
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Cardiovascular disorders are frequently found among chronic renal failure (CRF) patients due to their higher susceptibility to develop atherosclerosis. However, peripheral arterial disease (PAD), that is associated with a high mortality rate, is not usually assessed in these patients. The aims of this study are to find out the prevalence of PAD affecting lower limbs in a population of CRF patients in stages IV/V, and to assess how much PAD determines the 5-year patient survival. Methods. The study population (44 males and 29 females) was aged 58 +/- 15 years. They suffered from advanced CRF (18.6 +/- 6.1 ml/min creatinine clearance), but they were not on dialysis. These patients were sequentially referred initially to the predialysis unit over a period of 14 months. The vascular lesions were assessed by carotid and transcranial ultrasound, as well as by ankle-brachial index test (ABI). Routine 24 h blood and urine laboratory tests were performed for each patient. Cardiovascular morbidity and cardiovascular disease risk factors were evaluated through personal interview. Results. Fourteen patients had an ABI index of less than 0.91 (PAD indicative), 11 of them also suffered from intermittent claudication. PAD affected significantly more males (P = 0.001) and diabetics (P = 0.001). Also, PAD prevalence was significantly higher in patients with a previous clinical record of coronary heart disease (P = 0.001), increased clinical record of cerebrovascular disease (P = 0.005), a thickness of the left ventricular posterior wall (P = 0.03) and lower cardiac ejection fraction (P = 0.02). PAD patients had a significantly different protein intake (P = 0.003), calcium-phosphorus product (P = 0.001), risk of coronary heart disease based on the Framingham score (P = 0.001) and 5-year survival rate (P = 0.004). There were no significant differences for PAD patients in terms of body mass index, creatinine clearance, lipid profile, Ca and P. Multivariate risk factor analysis revealed that a previous clinical record of coronary heart disease and diabetes increased the risk of developing PAD, as defined by ABI < 0.91. After 5 years, 21 patients (29%) had died: 64% of patients that suffered PAD (9/14) and 20% of the non-PAD population (12/59). The Cox proportional hazards model demonstrated that older age and a lower ABI increased the risk of death. Conclusions. The present study, conducted on CRF patients in stages IV and V not undergoing dialysis, showed; (a) that a high percentage of these patients developed PAD (19%) or other vascular pathologies; (b) that there was an associated high mortality rate (29%) after 5 years; (c) that the 5-year mortality rate was significantly higher (P = 0.004) in PAD patients (64 vs 20%).
引用
收藏
页码:3525 / 3531
页数:7
相关论文
共 24 条
[11]   Ankle-arm index as a predictor of cardiovascular disease and mortality in the cardiovascular health study [J].
Newman, AB ;
Shemanski, L ;
Manolio, TA ;
Cushman, M ;
Mittelmark, M ;
Polak, JF ;
Powe, NR ;
Siscovick, D .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :538-545
[12]  
O'Hare A, 2001, J AM SOC NEPHROL, V12, P2838, DOI 10.1681/ASN.V12122838
[13]   Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease [J].
O'Hare, AM ;
Bertenthal, D ;
Shlipak, MG ;
Sen, S ;
Chren, MM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02) :514-519
[14]   High prevalence of peripheral arterial disease in persons with renal insufficiency - Results from the National Health and Nutrition Examination Survey 1999-2000 [J].
O'Hare, AM ;
Glidden, DV ;
Fox, CS ;
Hsu, CY .
CIRCULATION, 2004, 109 (03) :320-323
[15]   Dyslipidemia and progression of cardiovascular calcification (CVC) in patients with end-stage renal disease (ESRD) [J].
Qunibi, WY .
KIDNEY INTERNATIONAL, 2005, 67 :S43-S50
[16]   Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate [J].
Rahman, M ;
Pressel, S ;
Davis, BR ;
Nwachuku, C ;
Wright, JT ;
Whelton, PK ;
Barzilay, J ;
Batuman, V ;
Eckfeldt, JH ;
Farber, MA ;
Franklin, S ;
Henriquez, M ;
Kopyt, N ;
Louis, GT ;
Saklayen, M ;
Stanford, C ;
Walworth, C ;
Ward, H ;
Wiegmann, T .
ANNALS OF INTERNAL MEDICINE, 2006, 144 (03) :172-180
[17]  
ROLDAN C, 2004, HIPERTENSION, V21, P66
[18]  
ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645
[19]   Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level [J].
Siu, YP ;
Leung, KT ;
Tong, MKH ;
Kwan, TH .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (01) :51-59
[20]   Novel approaches in an integrated therapy of inflammatory-associated wasting in end-stage renal disease [J].
Stenvinkel, P ;
Lindholm, B ;
Heimbürger, O .
SEMINARS IN DIALYSIS, 2004, 17 (06) :505-515